STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables)

9 Months Ended

Sep. 30, 2020

Share-based Payment Arrangement [Abstract]

Schedule of weighted-average assumptions

The following table presents the weighted-average assumptions used to estimate the fair value of the stock options granted during the nine months ended September 30, 2020:

Risk Free Interest Rate		1.77	%
Expected Volatility		452.96	%
Expected Life (in years)		4.4
Dividend Yield		0	%
Weighted average estimated fair value of
options during the period	$	4.62

Schedule of stock option activity

	Options Outstanding
						Weighted -
						Average		Aggregate
						Remaining		Intrinsic
				Weighted-		Contractual		Value
	Number of			Average		Term		(in 000’s)
	Shares			Exercise Price		(in years)		(1)
Balance as of December 31, 2019	358,271			$5.91
Granted		133,000			3.85
Forfeited/Cancelled/Expired		(17,500	)		29.07
Balance as of September 30, 2020		473,771			$4.48
Exercisable as of September 30, 2020		436,771			$4.42		4.0	$49

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. 

Schedule of summary for the activities of unvested stock options

The following table summarizes the activities for the Company’s unvested stock options for the nine months ended September 30, 2020:

	Unvested Options
	Weighted - Average
	Number of Unvested			Grant Date
	Options			Exercise Price
Balance as of December 31, 2019	20,000		$	9.75
Granted	133,000			3.85
Vested	(116,000	)		4.44
Balance as of September 30, 2020	37,000		$	5.19

Schedule of warrant activity

The following table summarizes the activities for the Company’s warrants for the nine months ended September 30, 2020:

	Warrants Outstanding
		Number of Shares			Weighted- Average  Exercise Price	Weighted - Average  Remaining Contractual Term in years)		Aggregate Intrinsic Value (in 000's) (1)
Balance as of December 31, 2019		445,252		$	15.39
Granted		3,787,991			4.97
Cancelled/Forfeited		(454,000	)		7.50
Balance as of September 30, 2020		3,779,243		$	5.89	4.1
Exercisable as of September 30, 2020		3,605,330		$	5.93	4.3	$	-

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $3.22 for our common stock on September 30, 2020.